These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11396164)

  • 1. A novel culture environment for generating mature human dentritic cells from peripheral blood CD14+ cells.
    Tsiatas ML; Gritzapis AD; Cacoullos NT; Papadhimitriou SI; Baxevanis CN; Papamichail M
    Anticancer Res; 2001; 21(2A):1199-206. PubMed ID: 11396164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
    Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
    Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
    Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
    Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].
    He B; Qiu G; Xie X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of lymphokine-activated cytotoxic T lymphocytes stimulated by dendritic cells and autologous tumor from a patient with gastric cancer and their effects in vitro.
    Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2005; 52(61):289-92. PubMed ID: 15783052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
    Eksioglu EA; Mahmood SS; Chang M; Reddy V
    Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
    Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
    Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J; Jacobs P; Doffek K; Sugg SL
    J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
    Saijo Y; Hong X; Tanaka M; Tazawa R; Liu SQ; Saijo K; Ohno T; Koike K; Ohkuda K; Satoh K; Nukiwa T
    Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
    Zhong RK; Loken M; Lane TA; Ball ED
    Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells.
    Verdijk RM; Mutis T; Esendam B; Kamp J; Melief CJ; Brand A; Goulmy E
    J Immunol; 1999 Jul; 163(1):57-61. PubMed ID: 10384099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of leukemic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens.
    Lee JJ; Park MS; Park JS; Kang HK; Kim SK; Nguyen Pham TN; Zhu XW; Cho D; Nam JH; Kim YJ; Rhee JH; Chung IJ; Kim HJ
    J Clin Apher; 2006 Oct; 21(3):188-94. PubMed ID: 16570260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
    Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells.
    Czerniecki BJ; Carter C; Rivoltini L; Koski GK; Kim HI; Weng DE; Roros JG; Hijazi YM; Xu S; Rosenberg SA; Cohen PA
    J Immunol; 1997 Oct; 159(8):3823-37. PubMed ID: 9378970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.
    Yano Y; Ueda Y; Itoh T; Fuji N; Okugawa K; Naito K; Imura K; Kohara J; Hayashi T; Nakane K; Matsuura Y; Kawai K; Yamagishi H
    Oncol Rep; 2006 Jul; 16(1):147-52. PubMed ID: 16786138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.